Synthesis of ZnO nanoparticles from the medicinal plant Salvia fruticosa Mill.: Green approach for potential biomedical application against Zn deficiency in humans.

We hypothesized that we could prepare ZnO nanoparticles (ZnO NPs) as a biomedical application treatment of zinc deficiency in human populations. In this study, we report a formulation prepared using a low-cost method for the green synthesis of ZnO NPs by utilizing the medicinal species Salvia fruticosa as natural raw material and Zn(NO 3) 2 ∙6H 2 O as a Zn source. The final product was identified and characterized by elemental analysis using X-ray energy-scattering spectroscopy (EDS), ultraviolet–visible spectroscopy (UV-VIS Spectroscopy), X-ray powder diffraction (XRD), and morphometric analysis using scanning electron microscopy (SEM). Finally, crystallization was studied using transmission electron microscopy (TEM). Afterward, ZnO NPs thus produced were utilized for foliar spraying on S. fruticosa open cultures, and Zn fortification in the foliage. Then, their effects on the biosynthesis of essential oils, and Zn bioavailability to humans were studied through different modes of consumption. ZnO NPs produced using our method were spherical while some were hexagonal, with an average size of approximately 22 nm, based on XRD results. The green synthesis method devised in this study afforded ZnO NPs from Zn(NO 3) 2 ∙6H 2 O with a 95 % yield, and consequently yielded economic benefits with respect to the current market prices. Foliage Zn fortification and the desired features were successfully achieved using ZnO NPs, and the proper mode of consumption of this medicinal plant has been recommended in this study. In conclusion, the methodology described in this study enables eco-friendly green synthesis of ZnO NPs at a low cost using S. fruticosa and puts forward a contemporary and integrated biomedical use of ZnO NPs to treat disorders resulting from or related to Zn deficiency. [ABSTRACT FROM AUTHOR]